References
- Reich A, Ständer S, Szepietowski JC. Drug-induced pruritus: a review. Acta Derm Venereol, 2009, 89(3):236-244.
- Bagatin E, Costa CS. Antihistamines reduce isotretinoin-induced pruritus. Int J Dermatol, 2024, 63(7):839-840.
- Sibaud V. Dermatologic Reactions to Immune Checkpoint Inhibitors: Skin Toxicities and Immunotherapy. Am J Clin Dermatol, 2018, 19(3):345-361.
- Eshaq AM, Flanagan TW, Ba Abbad AA, et al. Immune Checkpoint Inhibitor-Associated Cutaneous Adverse Events: Mechanisms of Occurrence. Int J Mol Sci, 2024, 26(1):88.
- Beuers U, Wolters F, Oude Elferink RPJ. Mechanisms of pruritus in cholestasis: understanding and treating the itch. Nat Rev Gastroenterol Hepatol, 2023, 20(1):26-36.
- Kremer AE, Mettang T, Weisshaar E. Non-dermatological Challenges of Chronic Itch. Acta Derm Venereol, 2020, 100(2):adv00025.
- Yosipovitch G, Misery L, Proksch E, et al. Skin Barrier Damage and Itch: Review of Mechanisms, Topical Management and Future Directions, Acta Derm Venereol, 2019, 99(13):1201-1209.
- Di Bartolomeo L, Irrera N, Campo GM, et al. Drug-Induced Photosensitivity: Clinical Types of Phototoxicity and Photo-allergy and Pathogenetic Mechanisms. Front Allergy, 2022, 3:876695.
- Butler DC, Berger T, Elmariah S, et al. Chronic Pruritus: A Review. JAMA, 2024, 331(24):2114-2124.
- Papier A, Strowd LC. Atopic dermatitis: a review of topical nonsteroid therapy. Drugs Context, 2018, 7:212521.
- Reich A, Szepietowski JC. Opioid-induced pruritus: an update. Clin Exp Dermatol, 2010, 35(1):2-6.
- Benson JL, Campbell HE, Phillips CN. Opioid-induced pruritus. Consult Pharm, 2015, 30(4):221-7.
- Kim BS, Inan S, Ständer S, et al. Role of kappa-opioid and mu-opioid receptors in pruritus: Peripheral and central itch circuits. Exp Dermatol, 2022, 31(12):1900-1907.
- Thomas DA, Williams GM, Iwata K, et al. The medullary dorsal horn. A site of action of morphine in producing facial scratching in monkeys. Anesthesiology, 1993, 79(3):548-54.
- Wang Z, Jiang C, Yao H, et al. Central opioid receptors mediate morphine-induced itch and chronic itch via disinhibition. Brain, 2021, 144(2):665-681.
- Okutani H, Lo Vecchio S, Arendt-Nielsen L. Mechanisms and treatment of opioid-induced pruritus: Peripheral and central pathways. Eur J Pain, 2024, 28(2):214-230.
- Togashi Y, Umeuchi H, Okano K, et al. Antipruritic activity of the kappa-opioid receptor agonist, TRK-820. Eur J Pharmacol, 2002, 435(2-3):259-64.
- Charuluxananan S, Kyokong O, Somboonviboon W, et al. Nalbuphine versus ondansetron for prevention of intrathecal morphine-induced pruritus after cesarean delivery. Anesth Analg, 2003, 96(6):1789-1793.
- Tubog TD, Harenberg JL, Buszta K, et al. Use of Nalbuphine for Treatment of Neuraxial Opioid-Induced Pruritus: A Systematic Review and Meta-Analysis. AANA J, 2019, 87(3):222-230.
- Inan S, Dun NJ, Cowan A. Antipruritic Effect of Nalbuphine, a Kappa Opioid Receptor Agonist, in Mice: A Pan Antipruritic. Molecules, 2021, 26(18):5517.
- Moustafa AA, Baaror AS, Abdelazim IA. Comparative study between nalbuphine and ondansetron in prevention of intra-thecal morphine-induced pruritus in women undergoing cesarean section. Anesth Essays Res, 2016, 10(2):238-44.
- Sheen MJ, Ho ST, Lee CH, et al. Preoperative gabapentin prevents intrathecal morphine-induced pruritus after orthopedic surgery. Anesth Analg, 2008, 106(6):1868-72.
- Bussaratid V, Walsh DS, Wilairatana P, et al. Frequency of pruritus in Plasmodium vivax malaria patients treated with chloroquine in Thailand. Trop Doct, 2000, 30(4):211-4.
- Ballut PC, Siqueira AM, Orlando AC, et al. Prevalence and risk factors associated to pruritus in Plasmodium vivax patients using chloroquine in the Brazilian Amazon. Acta Trop, 2013, 128(3):504-8.
- Jiménez-Alonso J, Tercedor J, Reche I. Grupo Lupus Virgen de las Nieves. Antimalarial drugs and pruritus in patients with lupus erythematosus. Acta Derm Venereol, 2000, 80(6):458.
- Ademowo OG, Sodeinde O. Certain red cell genetic factors and prevalence of chloroquine-induced pruritus. Afr J Med Med Sci, 2002, 31(4):341-343.
- Ajayi AA, Kolawole BA, Udoh SJ. Endogenous opioids, mu-opiate receptors and chloroquine-induced pruritus: a double-blind comparison of naltrexone and promethazine in patients with malaria fever who have an established history of generalized chloroquine-induced itching. Int J Dermatol, 2004, 43(12):972-977.
- Onigbogi O, Ajayi AA, Ukponmwan OE. Mechanisms of chloroquine-induced body-scratching behavior in rats: evidence of involvement of endogenous opioid peptides. Pharmacol Biochem Behav, 2000, 65(2):333-7.
- Zhu J, Yang Y, Du L, et al. A regulatory role of the medial septum in the chloroquine-induced acute itch through local GABAergic system and GABAergic pathway to the anterior cingulate cortex. Biochem Biophys Res Commun, 2024, 721:150145.
- Ostadhadi S, Foroutan A, Haddadi NS, et al. Pharmacological evidence for the involvement of adenosine triphosphate sensitive potassium channels in chloroquine-induced itch in mice. Pharmacol Rep, 2017, 69(6):1295-1299.
- Metze D, Reimann S, Szepfalusi Z, Bohle B, Kraft D, Luger TA. Persistent pruritus after hydroxyethyl starch infusion therapy: a result of long-term storage in cutaneous nerves. Br J Dermatol, 1997, 136(4):553-559.
- Ständer S, Richter L, Osada N, Metze D. Hydroxyethyl starch-induced pruritus: clinical characteristics and influence of dose, molecular weight and substitution. Acta Derm Venereol. 2014, 94(3):282-287.
- Bork K. Pruritus precipitated by hydroxyethyl starch: a review. Br J Dermatol, 2005, 152(1):3-12.
- Ständer S, Bone HG, Machens HG, et al. Hydroxyethyl starch does not cross the blood-brain or the placental barrier but the perineurium of peripheral nerves in infused animals. Cell Tissue Res, 2002, 310(3):279-287.
- Ständer S, Szépfalusi Z, Bohle B, et al. Differential storage of hydroxyethyl starch (HES) in the skin: an immunoelectron-microscopical long-term study. Cell Tissue Res. 2001, 304(2):261-269.
- Kamann S, Flaig MJ, Korting HC. Hydroxyethyl starch-induced itch: relevance of light microscopic analysis of semithin sections and electron microscopy. J Dtsch Dermatol Ges, 2007, 5(3):204-208.
- Reimann S, Szépfalusi Z, Kraft D, et al. Hydroxyethylstärke-Speicherung in der Haut unter besonderer Berücksichtigung des Hydroxyethylstärke-assoziierten Juckreizes [Hydroxyeth-yl starch accumulation in the skin with special reference to hydroxyethyl starch-associated pruritus]. Dtsch Med Wochenschr, 2000, 125(10):280-285.
- Szeimies RM, Stolz W, Wlotzke U, Korting HC, et al. Successful treatment of hydroxyethyl starch-induced pruritus with topical capsaicin. Br J Dermatol, 1994, 131(3):380-2.
- Brune A, Metze D, Luger TA, et al. Antipruritische Therapie mit dem oralen Opiatrezeptorantagonisten Naltrexon. Offene, nicht placebokontrollierte Anwendung bei 133 Patienten [Antipruritic therapy with the oral opioid receptor antagonist nal-trexone. Open, non-placebo controlled administration in 133 patients]. Hautarzt, 2004, 55(12):1130-1136.
- Bhardwaj M, Chiu MN, Pilkhwal Sah S. Adverse cutaneous toxicities by PD-1/PD-L1 immune checkpoint inhibitors: pathogenesis, treatment, and surveillance. Cutan Ocul Toxicol, 2022, 41(1):73-90.
- Geisler AN, Phillips GS, Barrios DM, et al. Immune check-point inhibitor-related dermatologic adverse events. J Am Acad Dermatol. 2020 Nov, 83(5):1255-1268.
- Muntyanu A, Netchiporouk E, Gerstein W, et al. Cutaneous Immune-Related Adverse Events (irAEs) to Immune Check-point Inhibitors: A Dermatology Perspective on Management. J Cutan Med Surg. 2021, 25(1):59-76.
- Bayrak Durmaz MS, Unutmaz DG, Demir M, et al. Hyper-sensitivity Reactions to Taxanes: A Multicenter Study for Outcomes and Safety of Rapid Drug Desensitization. Allergy Asthma Immunol Res. 2024, 16(2):142-153.
- Tsao LR, Young FD, Otani IM, et al. Hypersensitivity Reactions to Platinum Agents and Taxanes. Clin Rev Allergy Immunol. 2022, 62(3):432-448.
- Villarreal-González RV, González-Díaz S, Vidal-Gutiérrez O, et al. Hypersensitivity Reactions to Taxanes: A Comprehensive and Systematic Review of the Enjcacy and Safety of De-sensitization. Clin Rev Allergy Immunol, 2023, 65(2):231-250.
- Shenoy ES, Macy E, Rowe T, et al. Evaluation and Management of Penicillin Allergy: A Review. JAMA, 2019, 321(2):188-199.
- Asyraf PA, Kusnadi IF, Stefanus J, et al. Clinical Manifestations and Genetic Influences in Sulfonamide-Induced Hyper-sensitivity. Drug Healthc Patient Saf, 2022, 14:113-124.
- Romano A, Gaeta F, Caruso C, et al. Evaluation and Updated Classification of Acute Hypersensitivity Reactions to Nonste-roidal Anti-Inflammatory Drugs (NSAIDs): NSAID-Exacerbat-ed or -Induced Food Allergy. J Allergy Clin Immunol Pract, 2023, 11(6):1843-1853.e1.
- Bianchi L, Hansel K, Biondi F, et al. Delayed hypersensitivity reactions to iodinated contrast media: A diagnostic approach by skin tests. Contact Dermatitis, 2023, 89(5):352-358.
- Kelesidis T, Fleisher J, Tsiodras S. Anaphylactoid reaction considered ciprofloxacin related: a case report and literature review. Clin Ther, 2010, 32(3):515-526.
- Hamamura-Yasuno E, Matsushita J, Sato S, et al. Determination of key residues in MRGPRX2 to enhance pseudo-allergic reactions induced by fluoroquinolones. Sci Rep, 2022; 12(1):6650.
- Liu R, Hu S, Zhang Y, et al. Mast cell-mediated hypersensitivity to fluoroquinolone is MRGPRX2 dependent. Int Immuno-pharmacol, 2019, 70:417-427.
- McNeil BD. MRGPRX2 and Adverse Drug Reactions. Front Immunol, 2021, 12:676354.
- Yegit OO, Gelmez MY, Demir S, et al. Diagnosis of cipro-floxacin hypersensitivity improves by incorporating MRG-PRX2 in basophil activation test. Allergy Asthma Proc, 2025, 46(3):247-256.
- Elst J, Maurer M, Sabato V, et al. Novel Insights on MRGPRX2-Mediated Hypersensitivity to Neuromuscular Blocking Agents And Fluoroquinolones. Front Immunol, 2021, 12:668962.
- Van Gasse AL, Elst J, Bridts CH, et al. Rocuronium Hyper-sensitivity: Does Off-Target Occupation of the MRGPRX2 Receptor Play a Role? J Allergy Clin Immunol Pract, 2019, 7(3):998-1003.
- Lyu S, Oliver ET, Dispenza MC, et al. A Skin Testing Strategy for Non-IgE-Mediated Reactions Associated With Vancomycin. J Allergy Clin Immunol Pract, 2024, 12(11):3025-3033.e6.
- Paus R, Schmelz M, Bíró T, et al. Frontiers in pruritus research: Scratching the brain for more effective itch therapy. J Clin Investig, 2006, 116, 1174-1185.